title: Pancreatic resection pain management: is combining PCA therapy and a continuous local infusion of 0.5% ropivacaine beneficial?
authors.forename: Traci K
authors.initials: TK
authors.lastname: Thompson
authors.forename: Rob W
authors.initials: RW
authors.lastname: Hutchison
authors.forename: Deborrah J
authors.initials: DJ
authors.lastname: Wegmann
authors.forename: G Tom
authors.initials: GT
authors.lastname: Shires
authors.forename: Ernest
authors.initials: E
authors.lastname: Beecherl
mesh_terms: D000328:Adult; D000577:Amides / Q000008:administration & dosage*; D016058:Analgesia, Patient-Controlled; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D000779:Anesthetics, Local / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D007263:Infusions, Parenteral; D008297:Male; D010147:Pain Measurement; D010149:Postoperative Pain / Q000209:etiology / Q000517:prevention & control*; D010180:Pancreatectomy / Q000009:adverse effects*; D016577:Pancreaticoduodenectomy / Q000009:adverse effects*; D012189:Retrospective Studies; D000077212:Ropivacaine; D016896:Treatment Outcome
chemical_list: D000577:Amides; D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D000077212:Ropivacaine